Vanguard Group
EPIX

Vanguard Group’s ESSA Pharma EPIX Stock Holding History

Vanguard Group’s Portfolio EPIX Stock Details EPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-11,180
Closed -$70K – 4625
2022
Q1 		$70K Sell
11,180
-59,917
-84% -$527K ﹤0.01% 4612
2021
Q4 		$1.01M Sell
71,097
-72,318
-50% -$806K ﹤0.01% 4264
2021
Q3 		$1.15M Buy
143,415
+67,917
+90% +$1.08M ﹤0.01% 4216
2021
Q2 		$2.16M Buy
+75,498
New +$2.19M ﹤0.01% 3949

Other funds holding EPIX

BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Vanguard Group's EPIX Position: Q2 2022 in Review

Vanguard Group sold out of ESSA Pharma (EPIX) in Q2 2022, closing a stake of 11,180 shares — an estimated $70K sold.

Vanguard Group first reported a position in EPIX in Q2 2021 and held it in 4 quarters. The position peaked at $2.16M in Q2 2021. 59 funds tracked by Wall St. Rank hold EPIX as of Q2 2022.

  • Vanguard Group reported no remaining ESSA Pharma position as of Q2 2022 after selling out during the quarter.
  • Vanguard Group sold 11,180 ESSA Pharma shares in Q2 2022, an estimated $70K.
  • Vanguard Group first reported a position in ESSA Pharma in Q2 2021 and held it in 4 quarters.
  • Vanguard Group's ESSA Pharma position peaked at $2.16M in Q2 2021.
  • 59 funds tracked by Wall St. Rank held ESSA Pharma as of Q2 2022.

Based on Vanguard Group's 13F filing for Q2 2022, filed 12 Aug 2022.